NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
ALRN Aileron Therapeutics
- 1.7500
- -0.0100-0.57%
Close Dec 20 16:00 ET
37.92MMarket Cap-0.61P/E (TTM)
1.8800High1.7000Low71.50KVolume1.7500Open1.7600Pre Close128.45KTurnover0.37%Turnover RatioLossP/E (Static)21.67MShares7.420052wk High0.75P/B33.99MFloat Cap1.610052wk Low--Dividend TTM19.42MShs Float309.6000Historical High--Div YieldTTM10.23%Amplitude1.0100Historical Low1.7960Avg Price1Lot Size
Aileron Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -132.87%-3.82M | -169.22%-8.39M | -13.09%-5.27M | 20.34%-19.81M | -135.68%-10.39M | 76.47%-1.64M | 45.19%-3.12M | 40.24%-4.66M | -4.68%-24.87M | 29.51%-4.41M |
| Net income from continuing operations | -220.03%-5.85M | -400.39%-8.94M | -48.84%-7.11M | 42.43%-15.73M | -61.40%-7.34M | 71.31%-1.83M | 77.64%-1.79M | 43.26%-4.78M | -4.45%-27.33M | 33.12%-4.55M |
| Operating gains losses | ---- | ---- | ---- | ---36K | ---10K | ---42K | --0 | --16K | ---- | ---- |
| Depreciation and amortization | --0 | -66.67%4K | 37.21%59K | -29.59%119K | 20.93%52K | -72.09%12K | -71.43%12K | 4.88%43K | 39.67%169K | 7.50%43K |
| Change In working capital | 13,918.18%1.52M | 114.03%223K | 813.10%1.63M | -1,381.19%-5.38M | -1,624.27%-3.55M | 98.93%-11K | -190.54%-1.59M | -118.10%-229K | 73.55%420K | -57.25%-206K |
| -Change in prepaid assets | 147.03%206K | -589.80%-480K | -25.10%185K | -96.84%51K | -84.78%144K | -7.09%-438K | -86.93%98K | -24.23%247K | 654.30%1.61M | 1,884.91%946K |
| -Change in payables and accrued expense | 69.32%723K | 123.95%404K | 141.76%195K | -404.14%-5.36M | -225.31%-3.64M | 173.37%427K | -262.84%-1.69M | -16.75%-467K | -270.79%-1.06M | -2,229.17%-1.12M |
| -Change in other current assets | --707K | --183K | 5,320.83%1.3M | ---3K | ---27K | --0 | --0 | --24K | --0 | --0 |
| -Change in other current liabilities | ---116K | --116K | -45.45%-48K | 49.61%-65K | 5.88%-32K | --0 | --0 | -6.45%-33K | -95.45%-129K | -13.33%-34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -132.87%-3.82M | -169.22%-8.39M | -13.09%-5.27M | 20.34%-19.81M | -135.68%-10.39M | 76.47%-1.64M | 45.19%-3.12M | 40.24%-4.66M | -4.68%-24.87M | 29.51%-4.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -38.79%16.2M | -102.02%-96K | -87.04%542K | 44.95%8.5M | -37.76%7.25M | 173.67%26.46M | 111.64%4.76M |
| Net PPE purchase and sale | ---- | ---- | ---- | --42K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net business purchase and sale | ---- | ---- | ---- | ---96K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | -38.58%16.25M | --0 | -88.04%500K | 44.95%8.5M | -37.76%7.25M | 173.85%26.46M | 111.64%4.76M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | -38.79%16.2M | -102.02%-96K | -87.04%542K | 44.95%8.5M | -37.76%7.25M | 173.67%26.46M | 111.64%4.76M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -446K | 15.79M | 15.79M | 0 | 0 | 0 | ||||
| Net common stock issuance | ---292K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --7.07M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | --15.79M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---446K | ---- | ---- | --15.79M | --15.79M | --0 | ---- | ---- | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 66.33%21.94M | 54.55%12.07M | 232.21%17.34M | 43.97%5.22M | 148.64%12.09M | 72.38%13.19M | 4.47%7.81M | 43.97%5.22M | -52.55%3.63M | -36.23%4.86M |
| Current changes in cash | -288.43%-4.27M | 83.40%9.87M | -303.59%-5.27M | 664.24%12.18M | 1,394.93%5.31M | 60.63%-1.1M | 2,907.82%5.38M | -32.74%2.59M | 139.71%1.59M | 108.87%355K |
| Effect of exchange rate changes | --0 | ---- | ---- | ---63K | ---63K | --0 | ---- | ---- | --0 | ---- |
| End cash Position | 46.16%17.68M | 66.33%21.94M | 54.55%12.07M | 232.21%17.34M | 232.21%17.34M | 148.64%12.09M | 72.38%13.19M | 4.47%7.81M | 43.97%5.22M | 43.97%5.22M |
| Free cash flow | -132.87%-3.82M | -169.22%-8.39M | -13.09%-5.27M | 20.34%-19.81M | -135.68%-10.39M | 76.47%-1.64M | 45.19%-3.12M | 40.24%-4.66M | -3.99%-24.87M | 29.51%-4.41M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.